Coeptis Therapeutics Holdings, Inc. - Warrants COEPW 深 滬
已收盤 08-29 16:00:00 美东时间
0.0272
+0.003
+11.02%
華盛通- 最 高0.033
- 今 開0.0296
- 成交量 1.08万股
- 最 低 0.0257
- 昨 收 0.0245
- 總市值 0
- 52周最高 0.0599
- 市盈率 靜 --
- 換手率 Infinity.00%
- 52周最低 0.0042
- 委 比 23.76%
- 總股本 --
- 歷史最高 1.74
- 量 比 0.29
- 振 幅 29.80%
- 歷史最低 0.0042
- 每 手 1
- 風險率 0.00%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Coeptis Therapeutics Q2 EPS $(1.17) Up From $(1.60) YoY, Sales $200.681K
Coeptis Therapeutics (NASDAQ:COEP) reported quarterly losses of $(1.17) per share. This is a 26.88 percent increase over losses of $(1.60) per share from the same period last year. The company reported $200.681 thousand
08-15 05:48
SHAREHOLDER ALERT: The M&A Class Action Firm Investigates the Merger: COEP, RHE, PPBI, and PORT
NEW YORK, July 3, 2025 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders...
07-04 05:31
Coeptis Therapeutics Files Form S-4 With SEC For Proposed Merger With Z Squared
Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) ("Coeptis" or the "Company"), a next-gen technology and biopharmaceutical company, is pleased to announce the filing of a registration statement on Form S-4 with the
06-26 20:37
SNAP Biosciences & Monarch Therapeutics Partner To Advance Snap-Car NK Cell Therapy
SNAP Biosciences, Inc a majority-owned subsidiary of Coeptis Therapeutics Holdings Inc. (NASDAQ:COEP) and Monarch Therapeutics Inc., a biotechnology company pioneering next-generation immunotherapies, today announced a
05-28 20:29
Dogecoin Up 9% In One Week: Is A Breakout Coming?
Dogecoin (CRYPTO: DOGE) is up 9% over the past week, with key technical signals suggesting a possible breakout.
04-29 19:55
Coeptis Therapeutics, Z Squared announce merger agreement
Coeptis Therapeutics (NASDAQ:COEP) and Z Squared have entered into a definitive merger agreement that will result in Z Squared becoming a wholly-owned subsidiary of Coeptis. Under the terms of the mer...
04-25 21:08
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers Harrow (NASDAQ:HROW) stock moved upwards by 15.8% to $27.0 during Mond...
03-18 05:05
Coeptis Therapeutics Secures Worldwide Development And Commercialization Rights To GEAR Cell Therapy Platform
• COEP forms GEAR Therapeutics, as a majority-owned subsidiary, to advance GEAR-modified natural killer (NK) cells into first-in-human studies for broad range of cancers and other therapeutic modalities.
03-11 20:35
Coeptis Therapeutics Regains Compliance With Nasdaq Listing Rules
Coeptis Therapeutics Holdings, Inc. (NASDAQ:COEP) (the "Company" or "Coeptis"), a biopharmaceutical company focused on pioneering cell therapy platforms for cancer, autoimmune, and infectious diseases, today announced it
01-22 21:04
快讯 | Coeptis Therapeutics Holdings Inc向SEC提交申请，出售多达392万股股份，销售股东为其出售。
Coeptis Therapeutics Holdings Inc Files for Resale of up to 3.92 Mln Shares by ...
01-11 06:02
